StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note released on ...

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

with a career-low 16.4% strikeout rate and a career-high 12.3% walk rate in 2024. Those secondary skills should ensure a solid offensive baseline to go with Kim’s elite glove, an attractive ...

Here's the latest news and everything you need to know about the first major wave of NFL player movement this spring.

Mar. 5, 2025 — A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

After hours: March 12 at 5:59:00 PM EDT Loading Chart for RVP ...

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against cancer.